Helvetica Chimica Acta – Vol. 91 (2008)
1265
eluted with toluene/AcOEt 1:1 was then separated by prep. TLC (CHCl3/MeOH 98 :2): omaezakianol
(2; 43.8 mg, 15%).
Omaezakianol (¼ rel-(a5R,2R,2’S,2’’S,2’’’S,5S,5’R,5’’R,5’’’R)-Hexadecahydro-a5,a5’’’,a5’’’,2,2’’,2’’’-hexa-
methyl-a5-(4-methylpent-3-en-1-yl)-[2,2’:5’,2’’:5’’,2’’’-quaterfuran]-5,5’’’-dimethanol; 2). Colorless oil.
1
[a]2D0 ¼ þ15.8 (c ¼ 0.59, CHCl3). IR (neat): 3455, 1340, 1318, 1302, 1183, 1078, 955, 925, 901, 755. H-
and 13C-NMR: Table. FD-MS: 509 (100, [M þ H]þ), 365 (8, [M À C8H15O2]þ), 227 (16, [M À C17H29O3]þ),
211 (5, [M À C17H29O4]þ), 143 (10, [M À C22H37O4]þ). FAB-MS (pos.): 509 (100, [M þ H]þ), 491 (64,
[M À H2O]þ), 227 (84, [M À C17H29O3]þ), 211 (40, [M À C17H29O4]þ), 143 (83, [M À C22H37O4]þ). HR-
FAB-MS (pos.): 509.3831 ([M þ H]þ, C30H53O6þ ; calc. 509.3842).
15,16-Anhydrothyrsiferol (¼(a2S,2R,5R)-a2-{(2E)-3-{(2R,4aR,6R,8aS)-6-[(2S,5R)-5-Bromotetra-
hydro-2,6,6-trimethyl-2H-pyran-2-yl]octahydro-8a-methylpyrano[3,2-b]pyran-2-yl}but-2-en-1-yl}tetrahy-
dro-a5,a5,2-trimethylfuran-2,5-dimethanol; 3). Amorphous solid. [a]D22 ¼ þ13.1 (c ¼ 0.53, CHCl3). IR
1
(CHCl3): 3650, 3520, 1159, 1147, 1125, 1105, 1078, 1045, 978, 915. H-NMR: 1.13 (s, Me(24)); 1.16 (s,
Me(29)); 1.20 (s, Me(26)); 1.21 (br. s, Me(27), Me(30)); 1.27 (s, Me(25)); 1.40 (s, Me(1)); 1.66 (s,
Me(28)); 1.50 – 1.93 (m, CH2(5), CH2(8), CH2(9), CH2(12), HaÀC(13), HaÀC(20), CH2(21)); 2.10 – 2.16
(m, HaÀC(4), HbÀC(13), HaÀC(17), HbÀC(20)); 2.18 – 2.30 (m, HbÀC(4), HbÀC(17)); 3.08 (dd, J ¼
11.5, 2.2, HÀC(7)); 3.47 (dd, J ¼ 11.2, 6.4, HÀC(11)); 3.56 (dd, J ¼ 9.8, 2.9, HÀC(18)); 3.76 (dd, J ¼
10.0, 6.1, HÀC(22)); 3.89 (dd, J ¼ 12.2, 3.9, HÀC(3)); 4.24 (dd, J ¼ 8.8, 3.9, HÀC(14)); 5.56 (dd, J ¼
7.3, 6.8, HÀC(16)). 13C-NMR: 13.04 (Me(28)); 19.90 (Me(27)); 20.12 (Me(26)); 23.67 (Me(1),
Me(29)); 24.03 (Me(24)); 27.71 (Me(30)); 31.04 (Me(25)); 21.82 (CH2(9)); 23.01 (CH2(8)); 25.82
(CH2(13)); 26.57 (CH2(21)); 28.29 (CH2(4)); 30.43 (CH2(17)); 32.01 (CH2(20)); 37.09 (CH2(5)); 38.77
(CH2(12)); 59.05 (CH(3)); 75.20 (CH(14)); 76.72 (CH(18)); 78.38 (CH(11)); 86.63 (CH(7)); 87.60
(CH(22)); 122.3 (CH(16)); 70.48 (C(23)); 72.46 (C(10)); 74.43 (C(6)); 74.69 (C(2)); 85.83 (C(19)); 138.9
(C(15)). FD-MS: 589 and 587 (30 and 32, [M þ H]þ), 445 and 443 (15 and 17, [M À C8H15O2]þ), 207 and
205 (20 and 19, [M À C22H37O5]þ), 143 (29, [M À C22H36BrO4]þ). EI-MS: 588 and 586 (0.3 and 0.3, Mþ),
570 and 568 (0.5 and 0.5, [M À H2O]þ), 529 and 527 (0.2 and 0.2, [M À C3H7O]þ), 445 and 443 (0.5 and
0.4, [M À C8H15O2]þ), 291 and 289 (2.9 and 2.8, [M À C17H29O4]þ), 143 (100, [M À C22H36BrO4]þ). HR-
EI-MS: 586.2852 (Mþ, C30H5719BrOþ6 ; calc. 586.2869).
Transformation of 2 into 5 and 6. To a soln. of 2 (10 mg) in CH2Cl2 (2 ml) were added 3-
chloroperbenzoic acid (9 mg) and Na2HPO4 · 12 H2O (5 mg), and the mixture was stirred for 3 h at 0 –
208. Then a trace of p-toluenesulfonic acid was added, and the mixture was further stirred for 1 h. The
mixture was extracted with CHCl3, and the CHCl3 soln. was successively shaken with sat. Na2S2O3/
Na2CO3 soln. 1:2 and sat. brine, dried (Na2SO4), and concentrated. The resulting material (13.5 mg) was
subjected to HPLC (hexane/CHCl3/MeOH 625 :370 :5, flow rate 1 ml/min, RI detector: 5 (4.2 mg, 41%;
tR 26 min) and 6 (4.5 mg, 44%; tR 38 min).
rel-(2R,2’S,2’’S,2’’’S,2’’’’S,5S,5’R,5’’R,5’’’R,5’’’’R)-Eicosahydrooctamethyl-a5,a5,a5’’’’,a5’’’’,2,2’’’,2’’’’,5’-
[2,2’:5’,2’’:5’’,2’’’:5’’’,2’’’’-quinquefuran]-5,5’’’’-dimethanol (5): Colorless oil. [a]1D7 ¼ þ0.59 (c ¼ 1.00,
CHCl3). IR (neat): 3455, 1338, 1319, 1302, 1260, 1183, 1080, 998, 955, 923, 900, 803, 755. 1H-NMR:
1.06 (s, Me(1), Me(30)); 1.14 (s, Me(26), Me(29)); 1.15 (s, Me(27), Me(28)); 1.24 (s, Me(24), Me(25));
1.45 (ddd, J ¼ 12.1, 8.7, 5.9, HaÀC(5), HaÀC(20)); 1.52 – 1.66 (m, HaÀC(8), HaÀC(9), HaÀC(12),
HaÀC(13), HaÀC(16), HaÀC(17)); 1.79 – 1.94 (m, HaÀC(4), HbÀC(8), HbÀC(12), HbÀC(13),
HbÀC(17), HaÀC(21)); 2.03 – 2.13 (m, HbÀC(4), HbÀC(9), HbÀC(16), HbÀC(21)); 2.25 (ddd, J ¼
12.0, 9.3, 7.3, HbÀC(5), HbÀC(20)); 3.73 (br. dd, J ¼ 5.4, 5.4, HÀC(3), HÀC(22)); 3.84 (dd, J ¼ 7.8,
5.9, HÀC(11), HÀC(14)); 4.02 (dd, J ¼ 10.3, 5.4, HÀC(7), HÀC(18)). 13C-NMR: 22.57 (Me(27),
Me(28)); 25.02 (Me(26), Me(29)); 25.29 (Me(1), Me(30)); 28.09 (Me(24), Me(25)); 26.56 (CH2(4),
CH2(21)); 27.09 (CH2(12), CH2(13)); 29.08 (CH2(8), CH2(17)); 31.00 (CH2(5), CH2(20)); 34.64 (CH2(9),
CH2(16)); 84.24 (CH(7), CH(18)); 84.60 (CH(11), CH(14)); 85.68 (CH(3), CH(22)); 71.67 (C(2),
C(23)); 83.98 (C(10), C(15)); 85.61 (C(6), C(19)). FD-MS: 525 (100, [M þ H]þ), 381 (25), 227 (29), 143
(27). FAB-MS (pos.): 525 (27, [M þ H]þ), 507 (20, [M þ HÀH2O]þ), 391 (23), 227 (31, [M À
C17H29O3]þ), 154 (100), 143 (54, [M À C22H37O4]þ). HR-FAB-MS (pos.): 525.3782 ([M þ H]þ,
C30H53Oþ7 ; calc. 525.3792). Spectral data in agreement with those of the synthetic meso compound
with a Cs symmetry [5].